Literature DB >> 27399954

Chlorhexidine Keratitis: Safety of Chlorhexidine as a Facial Antiseptic.

Kenneth D Steinsapir1, Julie A Woodward.   

Abstract

BACKGROUND: Effective antiseptic to reduce surgical site infections is a cornerstone of modern surgery. Chlorhexidine gluconate-based antiseptics are among the most effective of these products. Unfortunately, chlorhexidine solutions are toxic to the cornea and middle ear, and they pose a splash risk to both the patient and health care personnel.
OBJECTIVE: To examine the clinical evidence that led to the disavowal of chlorhexidine antiseptic solution for use on the face and head. METHODS AND MATERIALS: Reference searches were performed using PubMed, Embase, and LexisNexis databases without restriction to the date of publication, language, or study setting.
RESULTS: The literature revealed 11 sentinel cases of severe chlorhexidine-related keratitis in the late 1980s. These cases are reviewed together with data on ototoxicity and alternative products to understand why chlorhexidine solution should not be used on the face and scalp.
CONCLUSION: Chlorhexidine antiseptic solutions are highly effective. However, they pose a risk to the middle ear and have the potential to irreversibly damage the cornea with a minimal splash exposure. Povidone-iodine is a safe and effective alternative.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27399954     DOI: 10.1097/DSS.0000000000000822

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  9 in total

Review 1.  Guideline for the Prevention, Diagnosis, and Management of Acute Bacterial Soft Tissue Infections Following Nonsurgical Cosmetic Procedures.

Authors:  Emma Davies; Devan Vaghela; Cormac Convery; Lee Walker; Gillian Murray
Journal:  J Clin Aesthet Dermatol       Date:  2021-09-01

Review 2.  Improving aseptic injection standards in aesthetic clinical practice.

Authors:  Rachna Murthy; David Eccleston; Darren Mckeown; Apul Parikh; Sophie Shotter
Journal:  Dermatol Ther       Date:  2020-11-09       Impact factor: 2.851

Review 3.  Preventing complications in dermatologic surgery: Presurgical concerns.

Authors:  Allen G Strickler; Payal Shah; Shirin Bajaj; Richard Mizuguchi; Rajiv I Nijhawan; Mercy Odueyungbo; Anthony Rossi; Désirée Ratner
Journal:  J Am Acad Dermatol       Date:  2021-01-23       Impact factor: 15.487

Review 4.  Systematic review of ototoxic pre-surgical antiseptic preparations - what is the evidence?

Authors:  Shubhi Singh; Brian Blakley
Journal:  J Otolaryngol Head Neck Surg       Date:  2018-03-01

5.  Global Approaches to the Prevention and Management of Delayed-onset Adverse Reactions with Hyaluronic Acid-based Fillers.

Authors:  Wolfgang G Philipp-Dormston; Greg J Goodman; Koenraad De Boulle; Arthur Swift; Claudio Delorenzi; Derek Jones; Izolda Heydenrych; Ada Trindade De Almeida; Rami K Batniji
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-04-29

6.  Comparison of Skin Antiseptic Agents and the Role of 0.01% Hypochlorous Acid.

Authors:  Ann Q Tran; Nicole Topilow; Andrew Rong; Patrice J Persad; Michael C Lee; James H Lee; Apostolos G Anagnostopoulos; Wendy W Lee
Journal:  Aesthet Surg J       Date:  2021-09-14       Impact factor: 4.485

Review 7.  Fusarium Keratitis-Review of Current Treatment Possibilities.

Authors:  Marek Szaliński; Aleksandra Zgryźniak; Izabela Rubisz; Małgorzata Gajdzis; Radosław Kaczmarek; Joanna Przeździecka-Dołyk
Journal:  J Clin Med       Date:  2021-11-23       Impact factor: 4.241

Review 8.  Facial aesthetic injections in clinical practice: Pretreatment and posttreatment consensus recommendations to minimise adverse outcomes.

Authors:  Greg J Goodman; Steven Liew; Peter Callan; Sarah Hart
Journal:  Australas J Dermatol       Date:  2020-03-22       Impact factor: 2.875

Review 9.  Review: Perspective on ocular toxicity of presurgical skin preparations utilizing Chlorhexidine Gluconate/Hibiclens/Chloraprep.

Authors:  Nancy E Epstein
Journal:  Surg Neurol Int       Date:  2021-07-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.